Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Deciduous Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Deciduous Therapeutics

Deciduous Therapeutics

Seed

Deciduous Therapeutics: Innovating immune-modulatory therapies to remove senescent cells, improving health-span and treating age-related diseases.

HQ
San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Deciduous Therapeutics was founded with the mission to extend human health span by developing innovative immune-modulatory therapies that target and eliminate senescent cells. These cells, which accumulate due to a failure in immune surveillance, contribute to inflammation and tissue damage, driving many age-related diseases. The company's core vision is to harness the body's endogenous immune mechanisms to remove these harmful cells, thereby improving overall health and treating conditions associated with aging.

Notable figures affiliated with Deciduous Therapeutics include leading scientists and industry experts in immunology and aging. The company has attracted significant investment from prominent venture capital firms focused on biotechnology and healthcare innovation. Key achievements include pioneering research in senescence biology and advancing novel therapeutic candidates aimed at modulating the immune system. Deciduous Therapeutics' work has the potential to revolutionize the treatment of age-related diseases, offering new hope for enhancing longevity and quality of life.

Deciduous Therapeutics - Similar Companies

Dorian therapeutics logo

Dorian therapeutics

Fountain Therapeutics logo

Fountain Therapeutics

fountaintx.com

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Juvenescence logo

Juvenescence

juvlabs.com

Juvena Therapeutics logo

Juvena Therapeutics

Retro Biosciences logo

Retro Biosciences

retro.bio

HCW Biologics logo

HCW Biologics

hcwbiologics.com

Oisin Biotechnologies logo

Oisin Biotechnologies

oisinbio.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

DecImmune Therapeutics logo

DecImmune Therapeutics

decimmune.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

AgeX Therapeutics logo

AgeX Therapeutics

Therini Bio logo

Therini Bio

therinibio.com

Thymmune Therapeutics logo

Thymmune Therapeutics

thymmune.com

Deciduous Therapeutics - Quick Facts

Who are Deciduous Therapeutics' competitors?

Companies similar to Deciduous Therapeutics include Dorian therapeutics, Fountain Therapeutics, Deep Apple Therapeutics and Juvenescence.

When was Deciduous Therapeutics founded?

Deciduous Therapeutics was founded in 2018.

Where is Deciduous Therapeutics' headquarters located?

Deciduous Therapeutics' headquarters is located in San Francisco, CA, US.

When was Deciduous Therapeutics' last funding round?

Deciduous Therapeutics' most recent funding round was for $10M (USD) in December 2022.

How much has Deciduous Therapeutics raised to-date?

As of Dec 31, 2022, Deciduous Therapeutics has raised a total of $16.5M (USD).

How many employees does Deciduous Therapeutics have?

Deciduous Therapeutics has 37 employees as of Feb 5, 2024.

Deciduous Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified